One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by β2-agonists
- 23 March 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 337 (8743) , 717-720
- https://doi.org/10.1016/0140-6736(91)90289-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1Journal of Allergy and Clinical Immunology, 1990
- Heparin‐like anticoagulants in asthmaAllergy, 1987
- Diminished atherosclerotic arterial calcifications in asthma.Allergy, 1987
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987
- The mast cell as a primary effector cell in the pathegenesis of asthmaJournal of Allergy and Clinical Immunology, 1986
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Heparin and other sulfated polysaccharides as scavengers of superoxideJournal of Allergy and Clinical Immunology, 1982
- Prospects for an oral intalRespiratory Medicine, 1981
- Disodium cromoglycate—Mode of action and its possible relevance to the clinical use of the drugRespiratory Medicine, 1971